Chapter title |
Acute myeloblastic leukemia-associated antigens: detection and clinical importance.
|
---|---|
Chapter number | 59 |
Book title |
Modern Trends in Human Leukemia IV
|
Published in |
Haematology and blood transfusion, January 1981
|
DOI | 10.1007/978-3-642-67984-1_59 |
Pubmed ID | |
Book ISBNs |
978-3-54-010622-7, 978-3-64-267984-1
|
Authors |
Baker, M A, Roncari, D A, Taub, R N, Mohanakumar, T, Falk, J A, M. A. Baker, D. A. K. Roncari, R. N. Taub, T. Mohanakumar, J. A. Falk, Baker, M. A., Roncari, D. A. K., Taub, R. N., Mohanakumar, T., Falk, J. A. |
Abstract |
Antigenic compounds from the surface of leukemic myeloblasts are shed in vitro on short-term culture. Blast cells radiolabeled by lactoperoxidase iodination release soluble compounds that react immunologically with alloantisera to leukemia-associated antigens. Partially characterized soluble antigens were used to raise heteroantisera in monkeys that are selectively reactive with leukemic myeloblasts and unreactive with nonleukemic cells. Monkey heteroantisera were used to further characterize soluble leukemia antigens. Sera from patients with acute myeloblastic leukemia inhibit the reactivity of the heteroantisera, suggesting that soluble leukemic antigen is released in vivo as well. |
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.